The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $55.75

Today's change+0.76 +1.38%
Updated January 19 4:02 PM EST. Delayed by at least 15 minutes.
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $55.75

Today's change+0.76 +1.38%
Updated January 19 4:02 PM EST. Delayed by at least 15 minutes.

Fresenius Medical Care AG & Co KGaA Hits New 52-week High

Fresenius Medical Care AG & Co KGaA closed up Friday by (U.S.)$0.76 or 1.38% to (U.S.)$55.75 and setting a new 52-week high. Over the last five days, shares have gained 2.24% and outperformed the S&P 500 index over the last 52 weeks with a 38.44% increase in price.

Key company metrics

  • Open(U.S.) $55.53
  • Previous close(U.S.) $54.99
  • High(U.S.) $55.76
  • Low(U.S.) $55.41
  • Bid / Ask-- / --
  • YTD % change+6.09%
  • Volume127,759
  • Average volume (10-day)153,269
  • Average volume (1-month)145,714
  • Average volume (3-month)208,906
  • 52-week range(U.S.) $40.02 to (U.S.) $55.76
  • Beta0.48
  • Trailing P/E22.45×
  • P/E 1 year forward23.72×
  • Forward PEG2.70×
  • Indicated annual dividend(U.S.) $0.53
  • Dividend yield0.95%
  • Trailing EPS(U.S.) $2.48
Updated January 19 4:02 PM EST. Delayed by at least 15 minutes.
S&P TSX0.42%Sector:Industry:

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue4,3364,4714,5483,896
Total other revenue--------
Total revenue4,3364,4714,5483,896
Gross profit1,4241,4951,5921,323
Total cost of revenue2,9112,9762,9562,572
Total operating expense3,7273,8883,8973,242
Selling / general / administrative801900923617
Research & development28353235
Depreciation / amortization000--
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income609583651653
Interest income (expense), net non-operating-98-89-121-88
Gain (loss) on sale of assets--------
Other--------
Income before tax522488559572
Income after tax371338377396
Income tax, total152151182176
Net income309269308323
Total adjustments to net income--------
Net income before extra. items309269308323
Minority interest-62-69-69-73
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items309269308323
Inc. avail. to common incl. extra. items309269308323
Diluted net income309269308323
Dilution adjustment------0
Diluted weighted average shares307307306307
Diluted EPS excluding extraordinary itemsvalue per share1.010.881.011.05
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share1.010.881.011.05